Tag Archives: Another

Hey, naysayers: Bristol-Myers’ Celgene buy just chalked up another point in its favor

Bristol-Myers Squibb scored more bragging rights for its coming megamerger: The FDA is now officially reviewing one of the “Big 5” Celgene candidates touted as cornerstones of the deal. And it’s ozanimod, the blockbuster MS prospect whose application the FDA wouldn’t even consider last year. Regulators in both the U.S. and Europe accepted Celgene’s ozanimod filings to… Read More »

Apple Could Be Facing Another China Headache – The Motley Fool

The ongoing trade war between the United States and China could be set to take a significant toll on Apple‘s (NASDAQ:AAPL) business. Per a report from Nikkei Asian Review, following the arrest of Huawei CFO Meng Wanzhou in Canada at the request of the United States, “[many] Chinese businesses have told employees they will receive subsidies if… Read More »